Cytochromes P450 Expression Systems

Catalytically active cytochrome P450 enzymes have been successfully expressed in bacterial, yeast, and mammalian cells. A variety of expression vectors have been used, resulting in both transient and stable expression. The system of choice depends on the goals of a particular project. Factors such as expense, ease of use, and yields required should govern the decision whether to use bacterial, yeast, insect, or mammalian cDNA expression. High-level expression of mammalian P450s in bacteria usually requires modifications of the amino-terminal region of the enzyme. The Escherichia coli P450-OR fusion proteins may also come of age for use in fermentation-production processes for the chemical industry. Many cytochromes P450 have been expressed in yeast, with variable levels of expression. Baculovirus, albeit somewhat tedious in having to individualize expression conditions, can produce high levels of enzyme. The standard mammalian cell expression systems, both transient and stable, have been of tremendous value to drug metabolism and carcinogenesis research and will continue to play a role in these areas.

[1]  F. Guengerich,et al.  Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. , 1994, Archives of biochemistry and biophysics.

[2]  N. Harada,et al.  Baculovirus mediated high level expression of human placental aromatase (CYP19A1). , 1994, Biochemical and biophysical research communications.

[3]  A. Vickers,et al.  The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[4]  S. Kitareewan,et al.  Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. , 1994, Biochemistry.

[5]  V. N. Luzikov,et al.  Effects of amino‐terminus truncation in human cytochrome P450IID6 on its insertion into the endoplasmic reticulum membrane of Saccharomyces cerevisiae , 1993, FEBS letters.

[6]  C. Sengstag,et al.  Saccharomyces cerevisiae: an alternative source for human microsomal liver enzymes and its use in drug interaction studies. , 1993, Toxicology.

[7]  F. Gonzalez Molecular biology of human xenobiotic-metabolizing cytochromes P450: role of vaccinia virus cDNA expression in evaluating catalytic function. , 1993, Toxicology.

[8]  N. Harada,et al.  Core glycosylation of cytochrome P-450(arom). Evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen. , 1993, The Journal of biological chemistry.

[9]  F. Guengerich,et al.  Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. , 1993, Archives of biochemistry and biophysics.

[10]  Shiuan Chen,et al.  Structure-function studies of human aromatase , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  P. Ortiz de Montellano,et al.  Active sites of the cytochrome p450cam (CYP101) F87W and F87A mutants. Evidence for significant structural reorganization without alteration of catalytic regiospecificity. , 1993, The Journal of biological chemistry.

[12]  A. Seidel,et al.  Genetically engineered V79 Chinese hamster cells for stable expression of human cytochrome P450IA2. , 1992, European journal of pharmacology.

[13]  D. Mansuy,et al.  Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5. , 1992, European journal of biochemistry.

[14]  C. Sengstag,et al.  Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity. , 1992, Biochemical and biophysical research communications.

[15]  K. Korzekwa,et al.  Baculovirus-mediated expression and functional characterization of human NADPH-P450 oxidoreductase. , 1992, Archives of biochemistry and biophysics.

[16]  S. Boddupalli,et al.  Expression, purification, and properties of the flavoprotein domain of cytochrome P-450BM-3. Evidence for the importance of the amino-terminal region for FMN binding. , 1991, The Journal of biological chemistry.

[17]  T. Aoyama,et al.  Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. , 1991, Pharmacogenetics.

[18]  F. Gonzalez,et al.  A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. , 1991, Carcinogenesis.

[19]  K. Sethumadhavan,et al.  Estrogen synthetase (aromatase). The cytochrome P-450 component of the human placental enzyme is a glycoprotein , 1991, Molecular and Cellular Endocrinology.

[20]  D. Ohta,et al.  Expression and characterization of a rabbit liver cytochrome P450 belonging to P450IIB subfamily with the aid of the baculovirus expression vector system. , 1991, Biochemical and biophysical research communications.

[21]  F. Gonzalez,et al.  DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. , 1991, Mutation research.

[22]  F. Gonzalez,et al.  The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. , 1991, Carcinogenesis.

[23]  P. Beaune,et al.  Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme. , 1990, European journal of biochemistry.

[24]  M. J. Coon,et al.  Expression of rabbit cytochrome P-450IIE2 in yeast and stabilization of the enzyme by 4-methylpyrazole. , 1990, Biochemical and biophysical research communications.

[25]  J. S. Miles,et al.  Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. , 1990, The Biochemical journal.

[26]  T. Aoyama,et al.  Sequence requirements for cytochrome P-450IIB1 catalytic activity. Alteration of the stereospecificity and regioselectivity of steroid hydroxylation by a simultaneous change of two hydrophobic amino acid residues to phenylalanine. , 1989, The Journal of biological chemistry.

[27]  F. Gonzalez,et al.  Novel exogenous heme-dependent expression of mammalian cytochrome P450 using baculovirus. , 1989, Archives of biochemistry and biophysics.

[28]  O. Mcbride,et al.  Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping. , 1989, Biochemistry.

[29]  T. Aoyama,et al.  Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7. , 1989, Molecular pharmacology.

[30]  Y. Nogi,et al.  Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. , 1989, Molecular pharmacology.

[31]  T. Kamataki,et al.  Cloning of human cytochrome P-450 cDNA and its expression in Saccharomyces cerevisiae. , 1989, Biochemistry international.

[32]  S. Sligar,et al.  The roles of active site hydrogen bonding in cytochrome P-450cam as revealed by site-directed mutagenesis. , 1988, The Journal of biological chemistry.

[33]  K. Wüthrich,et al.  Secondary structure determination for alpha-neurotoxin from Dendroaspis polylepis polylepis based on sequence-specific 1H-nuclear-magnetic-resonance assignments. , 1988, European journal of biochemistry.

[34]  M. Waterman,et al.  Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. , 1986, Science.

[35]  H. Ohkawa,et al.  Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae. , 1985, DNA.

[36]  F. Studier,et al.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. , 1983, Journal of molecular biology.

[37]  T. D. Schneider,et al.  Characterization of Translational Initiation Sites in E. Coui , 1982 .

[38]  F. Gonzalez,et al.  Human Cells as an Expression System for Cytochromes P450 , 1994 .

[39]  A. Vickers,et al.  Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[40]  T. Aoyama,et al.  Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. , 1992, Chemical research in toxicology.

[41]  T. Poulos Modeling of mammalian P450s on basis of P450cam X-ray structure. , 1991, Methods in enzymology.

[42]  F. Gonzalez,et al.  Expression of mammalian cytochrome P450 using vaccinia virus. , 1991, Methods in Enzymology.

[43]  Y. Fujii‐Kuriyama,et al.  Functional analysis of mutant P450(C21) genes in COS cell expression system. , 1991, Methods in enzymology.

[44]  F. Guengerich,et al.  Expression of mammalian cytochrome P450 enzymes using yeast-based vectors. , 1991, Methods in enzymology.

[45]  F. Oesch,et al.  V79 Chinese hamster cells genetically engineered for stable expression of cytochromes P450. , 1991, Methods in enzymology.

[46]  R. Langenbach,et al.  The development of a panel of human cell lines expressing specific human cytochrome P450 cDNAs. , 1990, Progress in clinical and biological research.

[47]  W. Trager,et al.  Metabolism of the B-ring of testosterone by the rat cytochrome P-450 system. , 1989, Drug metabolism reviews.